Adlercreutz, H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3, 364–373.
Fletcher, RJ (2003) Food sources of phyto-oestrogens and their precursors in Europe. Br J Nutr 89, S39–S43.
Ososki, AL & Kennely, EJ (2003) Phytoestrogens: a review of the present state of research. Phytother Res 17, 845–869.
Rowland, IR, Faughnan, M, Hoey, L, Wähälä, K, Williamson, G & Cassidy, A (2003) Bioavailability of phyto-estrogens. Br J Nutr 89, S45–S58.
Blakesmith, SJ, Lyons-Wall, PM, Joannou, GE, Petocz, P & Samman, S (2005) Urinary isoflavonoid excretion is inversely associated with the ratio of protein to dietary fibre intake in young women. Eur J Nutr 59, 284–290.
Horner, NK, Kristal, AR, Prunty, J, Skor, HE, Potter, JD & Lampe, JW (2002) Dietary determinants of plasma enterolactone. Cancer Epidemiol Biomarkers Prev 11, 121–126.
Coldham, NG & Sauer, MJ (2001) Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem Toxicol 39, 1211–1224.
Heyerick, A, Vervarcke, S, Depypere, HT, Bracke, ME & De Keukeleire, D (2006) A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54, 164–175.
Milligan, SR, Kalita, JC, Heyerick, A, Rong, H, De Cooman, L & De Keukeleire, D (1999) Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 83, 2249–2252.
Schaefer, O, Hümpel, M, Fritzemeier, K-H, Bohlmann, R & Schleuning, W-D (2003) 8-prenylnaringenin is a potent ERα selective phytoestrogen present in hops and beer. J Steroid Biochem Mol Biol 84, 359–360.
Possemiers, S, Heyerick, A, Robbens, V, De Keukeleire, D & Verstraete, W (2005) Activation of pro-estrogens form hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 53, 6281–6288.
Guo, J, Nikolic, D, Chadwick, LR, Pauli, GF & van Breemen, RB (2006) Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol form hops (Humulus lupulus L.). Drug Metab Dispos 34, 1152–1159.
Nikolic, D, Li, Y, Chadwick, LR, Grubjesic, S, Schwab, P, Metz, P & van Breemen, RB (2004) Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus), by human liver microsomes. Drug Metab Dispos 32, 272–279.
Stevens, JF, Taylor, AW & Deinzer, ML (1999) Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr A 832, 97–107.
Possemiers, S, Bolca, S, Grootaert, C, Heyerick, A, Decroos, K, Dhooge, W, De Keukeleire, D, Rabot, S, Verstraete, W & Van de Wiele, T (2006) Isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136, 1862–1867.
Schaefer, O, Bohlmann, R, Schleuning, W-D, Schulze-Forster, K & Hümpel, M (2005) Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J Agric Food Chem 53, 2881–2889.
Rowland, IR, Wiseman, H, Sanders, TAB, Adlercreutz, H & Bowey, EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27–32.
Cummings, JH & Macfarlane, GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70, 443–459.
Frankenfeld, CL, Patterson, RE, Horner, NK, Neuhouser, ML, Skor, HE, Kalhorn, TF, Howald, WN & Lampe, JW (2003) Validation of a soy food frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr 77, 674–680.
Soares, ACF, Lederman, HM, Fagundes-Neto, U & de Morais, MB (2005) Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 39, 512–515.
Boeckx, P, Van Cleemput, O & Villaralvo, I (1996) Methane emission from a landfill and the methane oxidising capacity of its covering soil. Soil Biol Biochem 28, 1397–1405.
Hoey, L, Rowland, IR, Lloyd, AS, Clarke, DB & Wiseman, H (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91, 607–616.
Berg, JO, Nord, CE & Wadstrom, T (1978) Formation of glycosidases in batch and continuous cultures of Bacteroides fragilis. Appl Environ Microbiol 35, 269–273.
Superior Health Council (2006) .
Frankenfeld, CL, McTiernan, A, Tworoger, SS, et al. (2004) Serum steroid hormones, sex hormone-binding globulin concentrations and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol. 88, 399–408.
Pollock, BG, Wylie, M & Stack, JA (1999) Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 39, 936–940.
Avula, B, Ganzera, M, Warnick, JE, Feltenstein, MW, Sufka, KJ & Khan, IA (2004) High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine and fecal samples. J Chromatogr Sci 42, 378–382.
Gerhaüser, C, Alt, A, Heiss, E, et al. (2002) Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol Cancer Ther. 1, 959–969.
Nikolic, D, Li, Y, Chadwick, LR & van Breemen, RB (2006) In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen form hops (Humulus lupulus L.). Pharm Res 23, 864–872.
Rad, M, Hümpel, M, Schoemaker, RC, Schleuning, W-D, Cohen, AF & Burggraaf, J (2006) Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol 62, 288–296.
Setchell, KDR, Brown, NM, Desai, PB, Zimmer-Nechimias, L, Wolfe, B, Jakate, AS, Creutzinger, V & Heubi, JE (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027–1035.
Wiseman, H, Casey, K, Bowey, EA, Duffy, R, Davies, M, Rowland, IR, Lloyd, AS, Murray, A, Thompson, A & Clarke, DB (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80, 692–699.
Xu, X, Wang, H, Murphy, PA, Cook, L & Hendrich, S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825–832.
Karr, SC, Lampe, JW, Huchins, AM & Slavin, JL (1997) Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46–51.
Lampe, JW, Karr, SC, Hutchins, AM & Slavin, JL (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217, 335–339.
Bond, JH, Engel, RR & Levitt, MD (1971) Factors influencing pulmonary methane excretion in man. J Exp Med 133, 572–588.
Miller, TL & Wolin, MJ (1986) Methanogens in human and animal intestinal tracts. Syst Appl Microbiol 7(2-3), 223–229.
Fernandes, J, Wolever, TMS & Rao, AV (2000) Interrelationships between age, total dietary fiber intake and breath methane in humans. Nutr Res 20, 929–940.
Calloway, DH, Colasito, DJ & Mathews, RD (1966) Gases produced by human intestinal microflora. Nature 212, 1238–1239.
Frankenfeld, CL, Atkinson, C, Thomas, WK, Goode, EL, Gonzalez, A, Jokela, T, Wähälä, K, Schwartz, SM, Li, SS & Lampe, JW (2004) Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med 229, 902–913.
LeMarchand, L, Franke, AA, Custer, LJ, Wilkens, LR & Cooney, RV (1997) Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7, 11–19.
Rizzo, N, Hispard, E, Dolbeault, S, Dally, S, Leverge, R & Girre, C (1997) Impact of long-term ethanol consumption on CYP1A2 activity. Clin Pharmacol Ther 62, 505–509.
Higdon, JV & Frei, B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46, 101–123.
Gates, S & Miners, O (1999) Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. J Clin Pharmacol 47, 299–305.
Lampe, JW, Skor, HE, Wähälä, K, Howald, WN & Chen, C (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131, 740–744.
Vedrine, N, Mathey, J, Morand, C, Brandolini, M, Davicco, MJ, Guy, L, Remesy, C, Coxam, V & Manach, C (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60, 1039–1045.
Batterham, TJ, Shutt, DA, Hart, NK, Braden, AWH & Tweeddale, HJ (1971) Metabolism of intraruminally administered [4-14C]formononetin and [4-14C]biochanin A in sheep. Aust J Agric Res 22, 131–138.
Lundh, TJO, Pettersen, H & Kiessling, K (1988) Demethylation and conjugation of formononetin and daidzein in sheep and cow liver microsomes. J Agric Food Chem 36, 22–25.
Schmider, J, Greenblatt, DJ, Von Moltke, LL, Karsov, D, Vena, R, Friedman, HL & Shader, RI (1997) Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitors. J Clin Pharmacol 37, 193–200.
Milligan, SR, Kalita, JC, Pocock, V, Heyerick, A, De Cooman, L, Rong, H & De Keukeleire, D (2002) Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123, 235–242.